Skip to main content
. 2022 Mar 23;30:e20210583. doi: 10.1590/1678-7757-2021-0583

Table 5. Occurrence of adverse effects during the experimental period in different groups.

Adverse effect % of subjects
GC (n=15) GAtb (n=15) GProb (n=15)
Headache 0 60% 0
Stomachache 0 7% 0
Nausea or Vomiting 0 27% 0
Metallic taste in the mouth 0 33% 0
Diarrhea or abdominal pain 0 27% 0
 
Sleepiness 0 20% 0
Itchy skin 0 0% 0
Skin wounds 0 0% 0